The potential hazards of xenotransplantation: An overview

OIE Revue Scientifique et Technique

Volumn 24, Issue 1, 2005, Pages 323-334

  Takeuchi, Y ^a   Magre, S ^a   Patience, C ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Immerge Biotherapeutics Inc   (United States)

^c BIOGEN   (United States)

Author keywords

Alpha1,3 galactosyltransferase gene knock out; Endogenous retrovirus; Genetically modified pig; Pig; Pig tissue; Rejection; Xenotransplantation

Indexed keywords

SUS SCROFA;

EID: 23444437808     PISSN: 02531933     EISSN: None     Source Type: Journal    
DOI: 10.20506/rst.24.1.1575     Document Type: Review

References (118)

1. Akiyoshi D.E., Denaro M., Zhu H., Greenstein J.L., Banerjee P. & Fishman J.A. (1998). - Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J. Virol., 72 (5), 4503-4507.
2. Armstrong J.A., Porterfield J.S. & De Madrid A.T. (1971). - C-type virus particles in pig kidney cell lines. J. gen. Virol., 10 (2), 195-198.
3. Atkinson J.P., Oglesby T.J., White D., Adams E.A. & Liszewski M.K. (1991). - Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor. Clin. experim. Immunol., 86 (Suppl. 1), 27-30.
4. Auchincloss H. Jr & Sachs D.H. (1998). - Xenogeneic transplantation. Annu. Rev. Immunol., 16, 433-470.
5. Bartosch B., Stefanidis D., Myers R., Weiss R., Patience C. & Takeuchi Y. (2004). - Evidence and consequence of porcine endogenous retrovirus recombination. J. Virol., 78 (24), 13880-13890.
6. Bergelson J.M., Chan M., Solomon K.R., St John N.F., Lin H. & Finberg R.W. (1994). - Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. natl Acad. Sci. USA, 91 (13), 6245-6248.
7. Bergelson J.M., Mohanty J.G., Crowell R.L., St John N.F., Lublin D.M. & Finberg R.W. (1995). - Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol., 69 (3), 1903-1906.
8. Bhatti F.N., Zaidi A., Schmoeckel M., Cozzi E., Chavez G., Wallwork J., White D.J. & Friend P.J. (1998). - Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomy. Transplant. Proc., 30 (5), 2467.
9. Bock M. & Stoye J.P. (2000). - Endogenous retroviruses and the human germline. Curr. Opin. genet. Dev., 10 (6), 651-655.
10. Bracy J.L., Sachs D.H. & Iacomini J. (1998). - Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science, 281 (5384), 1845-1847.
11. Bracy J.L. & Iacomini J. (2000). - Induction of B-cell tolerance by retroviral gene therapy. Blood, 96 (9), 3008-3015.
12. Breese S.S. Jr (1970). - Virus-like particles occurring in cultures of stable pig kidney cell lines. Brief report. Arch. ges. Virusforsch., 30 (4), 401-404.
13. Brewer L.A., Lwamba H.C., Murtaugh M.P., Palmenberg A.C., Brown C. & Njenga M.K. (2001). - Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells. J. Virol., 75 (23), 11621-11629.
14. Byrne G.W., McCurry K.R., Martin M.J., McClellan S.M., Platt J.L. & Logan J.S. (1997). - Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation, 63 (1), 149-155.
15. Carrington C.A., Richards A.C., Tucker A.W., Peters A.L. & White D.J.G. (1996). - A line of transgenic pigs in which the expression of human decay-accelerating factor by endothelial cells increased in the presence of inflammatory stimuli. Xenotransplantation, 3, 87-91.
16. Check E. (2002). - Diabetes trial stirs debate on safety of xenotransplants. Nature, 419 (6902), 5.
17. Chua K.B. (2003). - Nipah virus outbreak in Malaysia. J. clin. Virol., 26 (3), 265-275.
18. Chua K.B., Goh K.J., Wong K.T., Kamarulzaman A., Tan P.S., Ksiazek T.G., Zaki S.R., Paul G., Lam S.K. & Tan C.T. (1999). - Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet, 354 (9186), 1257-1259.
19. Clark D.A., Fryer J.F., Tucker A.W., McArdle P.D., Hughes A.E., Emery V.C. & Griffiths P.D. (2003). - Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control. Xenotransplantation, 10 (2), 142-148.
20. Clarkson N.A., Kaufman R., Lublin D.M., Ward T., Pipkin P.A., Minor P.D., Evans D.J. & Almond J.W. (1995). - Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol., 69 (9), 5497-5501.
21. Costa C., Zhao L., Burton W.V., Rosas C., Bondioli K.R., Williams B.L., Hoagland T.A., Dalmasso A.P. & Fodor W.L. (2002). - Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation, 9 (1), 45-57.
22. Cozzi E. & White D.J. (1995). - The generation of transgenic pigs as potential organ donors for humans. Nature Med., 1 (9), 964-966.
23. Cozzi E., Bhatti F., Schmoeckel M., Chavez G., Smith K.G., Zaidi A., Bradley J.R., Thiru S., Goddard M., Vial C., Ostlie D., Wallwork J., White D.J. & Friend P.J. (2000). - Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation, 70 (1), 15-21.
24. Dai Y., Vaught T.D., Boone J., Chen S.H., Phelps C.J., Ball S., Monahan J.A., Jobst P.M., McCreath K.J., Lamborn A.E., Cowell-Lucero J.L., Wells K.D., Colman A., Polejaeva I.A. & Ayares D.L. (2002). - Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nature Biotechnol., 20 (3), 251-255.
25. Dalmasso A.P., Vercellotti G.M., Platt J.L. & Bach F.H. (1991). - Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation, 52 (3), 530-533.
26. Diamond L.E., McCurry K.R., Martin M.J., McClellan S.B., Oldham E.R., Platt J.L. & Logan J.S. (1996). - Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation, 61 (8), 1241-1249.
27. Dinsmore J.H., Manhart C., Raineri R., Jacoby D.B. & Moore A. (2000). - No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation, 70 (9), 1382-1389.
28. Dor F.J., Tseng Y.L., Cheng J., Moran K., Sanderson T.M., Lancos C.J., Shimizu A., Yamada K., Awwad M., Sachs D.H., Hawley R.J., Schuurman H.J. & Cooper D.K. (2004). - Alpha 1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation, 78 (1), 15-20.
29. Dorig R.E., Marcil A., Chopra A. & Richardson C.D. (1993). - The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell, 75 (2), 295-305.
30. Ehlers B., Ulrich S. & Goltz M. (1999). - Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses. J. gen. Virol., 80 (Pt 4), 971-978.
31. Ericsson T., Oldmixon B., Blomberg J., Rosa M., Patience C. & Andersson G. (2001). - Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J. Virol., 75 (6), 2765-2770.
32. Ericsson T.A., Takeuchi Y., Templin C., Quinn G., Farhadian S.F., Wood J.C., Oldmixon B.A., Suling K.M., Ishii J.K., Kitagawa Y., Miyazawa T., Salomon D.R., Weiss R.A. & Patience C. (2003). - Identification of receptors for pig endogenous retrovirus. Proc. natl Acad. Sci. USA, 100 (11), 6759-6764.
33. Fryer J.F., Griffiths P.D., Fishman J.A., Emery V.C. & Clark D.A. (2001). - Quantitation of porcine cytomegalovirus in pig tissues by PCR. J. clin. Microbiol., 39 (3), 1155-1156.
34. Galili U. (1993). - Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol. Today, 14 (10), 480-482.
35. Galili U. (2004). - Immune response, accommodation, and tolerance to transplantation carbohydrate antigens. Transplantation, 78 (8), 1093-1098.
36. Groth C.G., Korsgren O., Tibell A., Tollemar J., Moller E., Bolinder J., Ostman J., Reinholt F.P., Hellerstrom C. & Andersson A. (1994). - Transplantation of porcine fetal pancreas to diabetic patients. Lancet, 344 (8934), 1402-1404.
37. Halbur P.G., Kasorndorkbua C., Gilbert C., Guenette D., Potters M.B., Purcell R.H., Emerson S.U., Toth T.E. & Meng X.J. (2001). - Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J. clin. Microbiol., 39 (3), 918-923.
38. Hammer C. (2002). - Xenotransplantation for liver therapy or: Can porcine hepatocytes generate physiological functions sufficient for a human patient in ALF? Int. J. Artif. Organs, 25 (10), 1019-1028.
39. Hanger J.J., Bromham L.D., McKee J.J., O'Brien T.M. & Robinson W.F. (2000). - The nucleotide sequence of koala (Phascolarctos cinereus) retrovirus: a novel type C endogenous virus related to Gibbon ape leukemia virus. J. Virol., 74 (9), 4264-4272.
40. Harrison I., Takeuchi Y., Bartosch B. & Stoye J.P. (2004) - Determinants of high titer in recombinant porcine endogenous retroviruses. J. Virol., 78 (24), 13871-13879.
41. Heneine W., Tibell A., Switzer W.M., Sandstrom P., Rosales G.V., Mathews A., Korsgren O., Chapman L.E., Folks T.M. & Groth C.G. (1998). - No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet, 352 (9129), 695-699. Erratum: Lancet, 352 (9138), 1478.
42. Herring C., Cunningham D.A., Whittam A.J., Fernandez-Suarez X.M. & Langford G.A. (2001). - Monitoring xenotransplant recipients for infection by PERV. Clin. Biochem., 34 (1), 23-27.
43. Herring C., Quinn G., Bower R., Parsons N., Logan N.A., Brawley A., Elsome K., Whittam A., Fernandez-Suarez X.M., Cunningham D., Onions D., Langford G. & Scobie L. (2001). - Mapping full-length porcine endogenous retroviruses in a large white pig. J. Virol., 75 (24), 12252-12265.
44. Kolber-Simonds D., Lai L., Watt S.R., Denaro M., Arn S., Augenstein M.L., Betthauser J., Carter D.B., Greenstein J.L., Hao Y., Im G.S., Liu Z., Mell G.D., Murphy C.N., Park K.W., Rieke A., Ryan D.J., Sachs D.H., Forsberg E.J., Prather R.S. & Hawley R.J. (2004). - Production of alpha-1,3- galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. natl Acad. Sci. USA, 101 (19), 7335-7340.
45. Kroneman A., Cornelissen L.A., Horzinek M.C., de Groot R.J. & Egberink H.F. (1998). - Identification and characterization of a porcine torovirus. J. Virol., 72 (5), 3507-3511.
46. Lachmann P.J. (1991). - The control of homologous lysis. Immunol. Today, 12 (9), 312-315.
47. Lai L., Kolber-Simonds D., Park K.W., Cheong H.T., Greenstein J.L., Im G.S., Samuel M., Bonk A., Rieke A., Day B.N., Murphy C.N., Carter D.B., Hawley R.J. & Prather R.S. (2002). - Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science, 295 (5557), 1089-1092.
48. Le Tissier P., Stoye J.P., Takeuchi Y., Patience C. & Weiss R.A. (1997). - Two sets of human-tropic pig retrovirus. Nature, 389 (6652), 681-682.
49. Leventhal J.R., Dalmasso A.P., Cromwell J.W., Platt J.L., Manivel C.J., Bolman R.M. III & Matas A.J. (1993). - Prolongation of cardiac xenograft survival by depletion of complement. Transplantation, 55 (4), 857-865.
50. Lieber M.M., Benveniste R.E., Livingston D.M. & Todaro G.J. (1973). - Mammalian cells in culture frequently release type C viruses. Science, 182 (107), 56-59.
51. Lieber M.M., Sherr C.J., Todaro G.J., Benveniste R.E., Callahan R. & Coon H.G. (1975). - Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc. natl Acad. Sci. USA, 72 (6), 2315-2319.
52. Lucchiari N., Azimzadeh A., Wolf P., Regnault V. & Cinqualbre J. (1997). - In vivo and in vitro optimization of depletion of IgM and IgG xenoantibodies by immunoadsorption using cell membrane proteins. Artif. Organs, 21 (4), 278-286.
53. McCurry K.R., Kooyman D.L., Alvarado C.G., Cotterell A.H., Martin M.J., Logan J.S. & Platt J.L. (1995). - Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med., 1 (5), 423-427.
54. McMorrow I.M., Comrack C.A., Sachs D.H. & DerSimonian H. (1997). - Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation, 64 (3), 501-510.
55. Magre S., Takeuchi Y. & Bartosch B. (2003). - Xenotransplantation and pig endogenous retroviruses. Rev. med. Virol., 13 (5), 311-329.
56. Magre S., Takeuchi Y., Langford G., Richards A., Patience C. & Weiss R. (2004). - Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J. Virol., 78 (11), 5812-5819.
57. Martin J., Herniou E., Cook J., O'Neill R.W. & Tristem M. (1999). - Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. J. Virol., 73 (3), 2442-2449.
58. Martin U., Kiessig V., Blusch J.H., Haverich A., von der Helm K., Herden T. & Steinhoff G. (1998). - Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 352 (9129), 692-694.
59. Martin U., Winkler M.E., Id M., Radecke H., Arseniev L., Groteluschen R., Simon A.R. & Steinhoff G. (2000). - Transmission of pig endogenous retrovirus to primary human cells. Transplant. Proc., 32 (5), 1157.
60. Martin U., Winkler M.E., Id M., Radeke H., Arseniev L., Takeuchi Y., Simon A.R., Patience C., Haverich A. & Steinhoff G. (2000). - Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation, 7 (2), 138-142.
61. Meerloo T., Sheikh M.A., Bloem A.C., de Ronde A., Schutten M., van Els C.A., Roholl P.J., Joling P., Goudsmit J. & Schuurman H.J. (1993). - Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. J. gen. Virol., 74 (Pt 1), 129-135.
62. Meng X.J., Purcell R.H., Halbur P.G., Lehman J.R., Webb D.M., Tsareva T.S., Haynes J.S., Thacker B.J. & Emerson S.U. (1997). - A novel virus in swine is closely related to the human hepatitis E virus. Proc. natl Acad. Sci. USA, 94 (18), 9860-9865.
63. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., Purcell R.H. & Emerson S.U. (1998). - Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J. Virol., 72 (12), 9714-9721.
64. Miyagawa S., Hirose H., Shirakura R., Naka Y., Nakata S., Kawashima Y., Seya T., Matsumoto M., Uenaka A. & Kitamura H. (1988). - The mechanism of discordant xenograft rejection. Transplantation, 46 (6), 825-830.
65. Niebert M., Rogel-Gaillard C., Chardon P. & Tonjes R.R. (2002). - Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells. J. Virol., 76 (6), 2714-2720.
66. Oldmixon B.A., Wood J.C., Ericsson T.A., Wilson C.A., White-Scharf M.E., Andersson G., Greenstein J.L., Schuurman H.J. & Patience C. (2002). - Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J. Virol., 76 (6), 3045-3048.
67. Ott D.E. (2002). - Potential roles of cellular proteins in HIV-1. Rev. med. Virol., 12 (6), 359-374.
68. Paradis K., Langford G., Long Z., Heneine W, Sandstrom P., Switzer W.M., Chapman L.E., Lockey C., Onions D. & Otto E. (1999). - Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science, 285 (5431), 1236-1241.
69. Parker W, Saadi S., Lin S.S., Holzknecht Z.E., Bustos M. & Platt J.L. (1996). - Transplantation of discordant xenografts: a challenge revisited. Immunol. Today, 17 (8), 373-378.
70. Patience C., Takeuchi Y. & Weiss R.A. (1997). - Infection of human cells by an endogenous retrovirus of pigs. Nature Med., 3 (3), 282-286.
71. Patience C., Wilkinson D.A. & Weiss R.A. (1997). - Our retroviral heritage. Trends Genet., 13 (3), 116-120.
72. Patience C., Patton G.S., Takeuchi Y., Weiss R.A., McClure M.O., Rydberg L. & Breimer M.E. (1998). - No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet, 352 (9129), 699-701.
73. Patience C., Switzer W.M., Takeuchi Y., Griffiths D.J., Goward M.E., Heneine W., Stoye J.P. & Weiss R.A. (2001). - Multiple groups of novel retroviral genomes in pigs and related species. J. Virol., 75 (6), 2771-2775.
74. Paton N.I., Leo Y.S., Zaki S.R., Auchus A.P., Lee K.E., Ling A.E., Chew S.K., Ang B., Rollin P.E., Umapathi T., Sng I., Lee C.C., Lim E. & Ksiazek T.G. (1999). - Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet, 354 (9186), 1253-1256.
75. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., Ball S., Specht S.M., Polejaeva I.A., Monahan J.A., Jobst P.M., Sharma S.B., Lamborn A.E., Garst A.S., Moore M., Demetris A.J., Rudert W.A., Bottino R., Bertera S., Trucco M., Starzl T.E., Dai Y. & Ayares D.L. (2003). - Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299 (5605), 411-414.
76. Pitkin Z. & Mullon C. (1999). - Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif. Organs, 23 (9), 829-833.
77. Polejaeva I.A., Chen S.H., Vaught T.D., Page R.L., Mullins J., Ball S., Dai Y., Boone J., Walker S., Ayares D.L., Colman A. & Campbell K.H. (2000). - Cloned pigs produced by nuclear transfer from adult somatic cells. Nature, 407 (6800), 86-90.
78. Powell R.M., Schmitt V., Ward T., Goodfellow I., Evans D.J. & Almond J.W. (1998). - Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J. gen. Virol., 79 (Pt 7), 1707-1713.
79. Pruitt S.K., Kirk A.D., Bollinger R.R., Marsh H.C. Jr, Collins B.H., Levin J.L., Mault J.R., Heinle J.S., Ibrahim S., Rudolph A.R. et al. (1994). - The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation, 57 (3), 363-370.
80. Quinn G., Wood J.C., Ryan D.J., Suling K.M., Moran K.M., Kolber-Simonds D.L., Greenstein J.L., Schuurman H.J., Hawley R.J. & Patience C. (2004). - Porcine endogenous retrovirus transmission characteristics of galactose alpha 1-3 galactose-deficient pig cells. J. Virol., 78 (11), 5805-5811.
81. Sablinski T., Gianello P.R., Bailin M., Bergen K.S., Emery D.W., Fishman J.A., Foley A., Hatch T., Hawley R.J., Kozlowski T., Lorf T., Meehan S., Monroy R., Powelson J.A., Colvin R.B., Cosimi A.B. & Sachs D.H. (1997). - Pig to monkey bone marrow and kidney xenotransplantation. Surgery, 121 (4), 381-391.
82. Saifuddin M., Hedayati T., Atkinson J.P., Holguin M.H., Parker C.J. & Spear G.T. (1997). - Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. gen. Virol., 78 (Pt 8), 1907-1911.
83. Sandrin M.S., Fodor W.L., Mouhtouris E., Osman N., Cohney S., Rollins S.A., Guilmette E.R., Setter E., Squinto S.P. & McKenzie I.F. (1995). - Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med., 1 (12), 1261-1267.
84. Santos N., Lima R.C., Nozawa C.M., Linhares R.E. & Gouvea V. (1999). - Detection of porcine rotavirus type G9 and of a mixture of types G1 and G5 associated with Wa-like VP4 specificity: evidence for natural human-porcine genetic reassortment. J. clin. Microbiol., 37 (8), 2734-2736.
85. Schmoeckel M., Bhatti F.N., Zaidi A., Cozzi E., Waterworth P.D., Tolan M.J., Pino-Chavez G., Goddard M., Warner R.G., Langford G.A., Dunning J.J., Wallwork J. & White D.J. (1998). - Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation, 65 (12), 1570-1577. Erratum: Transplantation, 66 (7), 943.
86. Schuurman H.J., Pino-Chavez G., Phillips M.J., Thomas L., White D.J. & Cozzi E. (2002). - Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation, 73 (7), 1146-1151.
87. Scobie L., Taylor S., Wood J.C., Suling K.M., Quinn G., Meikle S., Patience C., Schuurman H.J. & Onions D.E. (2004). - Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature swine. J. Virol., 78 (5), 2502-2509.
88. Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F. & Barry R.D. (1995). - Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol., 69 (6), 3873-3877.
89. Shafren D.R., Dorahy D.J., Ingham R.A., Burns G.F. & Barry R.D. (1997). - Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol., 71 (6), 4736-4743.
90. Sharma A., Okabe J., Birch P., McClellan S.B., Martin M.J., Platt J.L. & Logan J.S. (1996). - Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc. natl Acad. Sci. USA, 93 (14), 7190-7195.
91. Soin B., Smith K.G., Zaidi A., Cozzi E., Bradley J.R., Ostlie D.J., Lockhart A., White D.J. & Friend P.J. (2001). - Physiological aspects of pig-to-primate renal xenotransplantation. Kidney int., 60 (4), 1592-1597.
92. Swindle M.M. (1998). - Defining appropriate health status and management programs for specific-pathogen-free swine for xenotransplantation. Ann. N.Y. Acad. Sci., 862, 111-120.
93. Takefman D.M., Spear G.T., Saifuddin M. & Wilson C.A. (2002). - Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J. Virol., 76 (4), 1999-2002.
94. Takeuchi Y., Cosset F.L., Lachmann P.J., Okada H., Weiss R.A. & Collins M.K. (1994). - Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol., 68 (12), 8001-8007.
95. Takeuchi Y., Porter C.D., Strahan K.M., Preece A.F., Gustafsson K., Cosset F.L., Weiss R.A. & Collins M.K. (1996). - Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature, 379 (6560), 85-88.
96. Takeuchi Y., Patience C., Magre S., Weiss R.A., Banerjee P.T., Le Tissier P. & Stoye J.P. (1998). - Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol., 72 (12), 9986-9991.
97. Tatsuo H., Ono N., Tanaka K. & Yanagi Y. (2000). - SLAM (CDw150) is a cellular receptor for measles virus. Nature, 406 (6798), 893-897.
98. Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E. & Fanning T.G. (1997). - Initial genetic characterization of the 1918 'Spanish' influenza virus. Science, 275 (5307), 1793-1796.
99. Tearle R.G., Tange M.J., Zannettino Z.L., Katerelos M., Shinkel T.A., Van Denderen B.J., Lonie A.J., Lyons I., Nottle M.B., Cox T., Becker C., Peura A.M., Wigley P.L., Crawford R.J., Robins A.J., Pearse M.J. & d'Apice A.J. (1996). - The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation, 61 (1), 13-19.
100. Thall A.D., Maly P. & Lowe J.B. (1995). - Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Mol. Chem., 270 (37), 21437-21440.
101. Todaro G.J., Benveniste R.E., Lieber M.M. & Sherr C.J. (1974). - Characterization of a type C virus released from the porcine cell line PK(15). Virology, 58 (1), 65-74.
102. Tonjes R.R. & Niebert M. (2003). - Relative age of proviral porcine endogenous retrovirus sequences in Sus scrofa based on the molecular clock hypothesis. J. Virol., 77 (22), 12363-12368.
103. Tseng Y.L., Dor F.J., Kuwaki K., Ryan D., Wood J., Denaro M., Giovino M., Yamada K., Hawley R., Patience C., Schuurman H.J., Awwad M., Sachs D.H. & Cooper D.K. (2004). - Bone marrow transplantation from alpha1,3- galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation, 11 (4), 361-370.
104. Ulrich S., Goltz M. & Ehlers B. (1999). - Characterization of the DNA polymerase loci of the novel porcine lymphotropic herpesviruses 1 and 2 in domestic and feral pigs. J. gen. Virol., 80 (Pt 12), 3199-3205.
105. United States Food and Drug Administration (2004). - Xenotransplantation Action Plan. Website: http://www.fda.gov/cber/xap/xap.htm (accessed on 10 November 2004).
106. Wain-Hobson S. (1998). - Immunodeficiency viruses. 1959 and all that. Nature, 391 (6667), 531-532.
107. Ward T, Pipkin P.A., Clarkson N.A., Stone D.M., Minor P.D. & Almond J.W. (1994). - Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J., 13 (21), 5070-5074.
108. Weiss R.A. (1998). - Transgenic pigs and virus adaptation. Nature, 391 (6665), 327-328.
109. Wells D.L., Hopfensperger D.J., Arden N.H., Harmon M.W., Davis J.P., Tipple M.A. & Schonberger L.B. (1991). - Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA, 265 (4), 478-481.
110. Williams T.P., Kasorndorkbua C., Halbur P.G., Haqshenas G., Guenette D.K., Toth T.E. & Meng X.J. (2001). - Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. clin. Microbiol., 39 (9), 3040-3046.
111. Wilson C.A., Wong S., Muller J., Davidson C.E., Rose T.M. & Burd P. (1998). - Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol., 72 (4), 3082-3087.
112. Wood J.C., Quinn G., Suling K.M., Oldmixon B.A., Van Tine B.A., Cina R., Arn S., Huang C.A., Scobie L., Onions D.E., Sachs D.H., Schuurman H.J., Fishman J.A. & Patience C. (2004). - Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J. Virol., 78 (5), 2494-2501.
113. Xu Y., Lorf T., Sablinski T., Gianello P., Bailin M., Monroy R., Kozlowski T., Awwad M., Cooper D.K. & Sachs D.H. (1998). - Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation, 65 (2), 172-179.
114. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., O'Malley P., Nobori S., Vagefi P.A., Patience C., Fishman J., Cooper D.K., Hawley R.J., Greenstein J., Schuurman H.J., Awwad M., Sykes M. & Sachs D.H. (2005). - Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med., 11 (1), 32-34.
115. Ye Y., Neethling F.A., Niekrasz M., Koren E., Richards S.V., Martin M., Kosanke S., Oriol R. & Cooper D.K. (1994). - Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation, 58 (3), 330-337.
116. Yeatman M., Daggett C.W., Parker W., Byrne G.W., Logan J.S., Platt J.L. & Davis R.D. (1998). - Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation, 65 (8), 1084-1093.
117. Zaidi A., Schmoeckel M., Bhatti F., Waterworth P., Tolan M., Cozzi E., Chavez G., Langford G., Thiru S., Wallwork J., White D. & Friend P. (1998). - Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation, 65 (12), 1584-1590.
118. Zhu T., Korber B.T., Nahmias A.J., Hooper E., Sharp P.M. & Ho D.D. (1998). - An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature, 391 (6667), 594-597.